Dioxolanic amine with pharmacological activity, its method of
preparation, the pharmaceutical compositions containing same and their
use in human medicine
    2.
    发明授权
    Dioxolanic amine with pharmacological activity, its method of preparation, the pharmaceutical compositions containing same and their use in human medicine 失效
    具有药理活性的二氧戊环胺,其制备方法,含有它们的药物组合物及其在人类药物中的用途

    公开(公告)号:US4495199A

    公开(公告)日:1985-01-22

    申请号:US432397

    申请日:1982-09-30

    CPC分类号: C07D407/04

    摘要: A new dioxolanic amine is disclosed, with pharmacological activity of the following structural formula I: ##STR1## as well as its pharmaceutically acceptable salts, possessing intense vasodilatory, anti-angina and anti-arrhythmic activity, accompanied by a low toxicity; its method of preparation; pharmaceutical compositions containing the said compounds; and the treatment and prevention various pathological conditions with the use of said compositions. Also disclosed are new dioxolanic compound of the following structural formula II: ##STR2## which is an intermediate compound in the preparation of the formula I compound; and its method of preparation.

    摘要翻译: 公开了一种新的二氧戊环胺,其具有以下结构式I的药理学活性:其具有强烈的血管舒张,抗心绞痛和抗心律不齐活性,伴有低毒性的药学上可接受的盐; 其制备方法; 含有所述化合物的药物组合物; 以及使用所述组合物治疗和预防各种病理状况。 还公开了以下结构式II的新二氧戊环化合物:作为式I化合物的制备中的中间体化合物: 及其制备方法。

    Pharmaceutical compositions containing dextrorphan for intranasal
application
    4.
    发明授权
    Pharmaceutical compositions containing dextrorphan for intranasal application 失效
    用于鼻内施用的含有右旋糖的药物组合物

    公开(公告)号:US5019579A

    公开(公告)日:1991-05-28

    申请号:US445106

    申请日:1989-12-07

    IPC分类号: A61K9/00 A61K31/485

    摘要: The object of the invention is a pharmaceutically acceptable composition suitable to achieve a systemic therapeutical response due to its antitussis action in warm-blooded animals, characterized in that it contains, per dosage unit: (I) an amount therapeutically efficacious by systemic way due to the antitussis action of salified dextrorphan, and (II) a pharmaceutically non-toxic excipient acceptable for intranasal administering.

    摘要翻译: 本发明的目的是一种药学上可接受的组合物,其适用于由于其在温血动物中的镇咳作用而实现全身治疗反应,其特征在于每剂量单位含有:(I)由于 盐化右旋的镇咳作用,和(II)可用于鼻内给药的药学上无毒的赋形剂。

    Scopolamine derivatives for treating ulcers and spasms
    6.
    发明授权
    Scopolamine derivatives for treating ulcers and spasms 失效
    用于治疗溃疡和痉挛的东莨菪碱衍生物

    公开(公告)号:US3952108A

    公开(公告)日:1976-04-20

    申请号:US490266

    申请日:1974-07-22

    IPC分类号: C07D451/10 A61K31/46

    CPC分类号: C07D451/10 Y10S514/925

    摘要: The specification describes quaternary bromides of scopolamine in which the substituent on the nitrogen atom has the formula --(CH.sub.2).sub.n -R in which R represents a cycloalkyl group containing up to six carbon atoms, an alkyl-substituted cycloalkyl group containing up to six carbon atoms or an epoxyethyl group and n is 1 or 2. Such compounds have valuable spasmolytic and anti-ulcer properties and pharmaceutical preparations containing them are also described.

    摘要翻译: 该说明书描述了东莨菪碱的四溴化物,其中氮原子上的取代基具有式 - (CH 2)n R,其中R表示含有至多6个碳原子的环烷基,含有至多6个碳原子的烷基取代的环烷基或 环氧乙基,n为1或2.这些化合物具有有价值的解痉和抗溃疡性质,还描述了含有它们的药物制剂。